Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis

Hepatology

Volumn 41, Issue 3, 2005, Pages 660-667

  Kamegaya, Yoshitaka ^a   Hiasa, Yoichi ^a   Zukerberg, Lawrence ^a   Fowler, Nina ^b   Blackard, Jason T ^a   Lin, Wenyu ^a   Choe, Won H ^a   Schmidt, Emmett V ^a,b,c   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; FAS ANTIBODY; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS CORE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL PROLIFERATION; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; HEPACIVIRUS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; VIRAL ENVELOPE PROTEINS;

EID: 14244261930     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20621     Document Type: Article

References (19)

1. Lauer GM WB. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
2. Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, et al. Transgenic expression of hepatitis C virus structural proteins in the mouse. HEPATOLOGY 1997;25:1014-1021.
3. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031-3038.
4. Koike K, Moriya K, Kimura S. Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis. J Gastroenterol Hepatol 2002;17:394-400.
5. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527-1531.
6. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1067.
7. Kashiwakuma T, Hasegawa A, Kajita T, Takata A, Mori H, Ohta Y, et al. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods 1996;190:79-89.
8. Shiota G, Harada K, Ishida M, Tomie Y, Okubo M, Katayama S, et al. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine- treated mice. Carcinogenesis 1999;20:59-63.
9. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-365.
10. Pasquinelli C, Shoenberger JM, Chung J, Chang KM, Guidotti LG, Selby M, et al. Hepatitis C virus core and E2 protein expression in transgenic mice. HEPATOLOGY 1997;25:719-727.
11. Sell S, Hunt JM, Dunsford HA, Chisari FV. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 1991;51:1278-1285.
12. Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. HEPATOLOGY 1995;21:620-626.
13. Honda A, Arai Y, Hirota N, Sato T, Ikegaki J, Koizumi T, et al. Hepatitis C virus structural proteins induce liver cell injury in transgenic mice. J Med Virol 1999;59:281-289.
14. Dumoulin FL, van dem Bussche A, Sohne J, Sauerbruch T, Spengler U. Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. Eur J Clin Invest 1999;29:940-946.
15. Lasarte JJ, Sarobe P, Boya P, Casares N, Arribillaga L, de Cerio AL, et al. A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage. HEPATOLOGY 2003;37:461-470.
16. Roomi MW, Farber E, Parke DV. Changes in drug-metabolizing enzymes of rats in ciprofibrate-induced hepatic nodules. Xenobiotica 1997;27:951-960.
17. Thirunavukkarasu C, Sakthisekaran D. Sodium selenite modulates tumor marker indices in N-nitrosodiethylamine-initiated and phenobarbital-promoted rat liver carcinogenesis. Cell Biochem Funct 2003;21:147-153.
18. Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama K, et al. Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2′- deoxyguanosine formation. HEPATOLOGY 2002;35:1125-1133.
19. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61:4365-4370.